Reviewing HOYA (OTCMKTS:HOCPY) & Coloplast A/S (OTCMKTS:CLPBF)

HOYA (OTCMKTS:HOCPYGet Free Report) and Coloplast A/S (OTCMKTS:CLPBFGet Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership.

Profitability

This table compares HOYA and Coloplast A/S’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
HOYA 21.50% 19.46% 15.42%
Coloplast A/S N/A N/A N/A

Institutional & Insider Ownership

0.0% of HOYA shares are owned by institutional investors. Comparatively, 15.1% of Coloplast A/S shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and target prices for HOYA and Coloplast A/S, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HOYA 0 0 1 0 3.00
Coloplast A/S 0 0 0 0 N/A

Earnings and Valuation

This table compares HOYA and Coloplast A/S’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
HOYA $5.36 billion 8.43 $1.26 billion $3.37 38.17
Coloplast A/S N/A N/A N/A $11.42 12.06

HOYA has higher revenue and earnings than Coloplast A/S. Coloplast A/S is trading at a lower price-to-earnings ratio than HOYA, indicating that it is currently the more affordable of the two stocks.

Dividends

HOYA pays an annual dividend of $0.44 per share and has a dividend yield of 0.3%. Coloplast A/S pays an annual dividend of $7.50 per share and has a dividend yield of 5.4%. HOYA pays out 13.1% of its earnings in the form of a dividend. Coloplast A/S pays out 65.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

HOYA beats Coloplast A/S on 7 of the 10 factors compared between the two stocks.

About HOYA

(Get Free Report)

HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it engages in the research, development, manufacture, and sale of photomasks for manufacturing flat panel displays. Additionally, the company offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke, a time and attendance management service, as well as Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.

About Coloplast A/S

(Get Free Report)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Receive News & Ratings for HOYA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HOYA and related companies with MarketBeat.com's FREE daily email newsletter.